Bismuth subcitrate is an antibiotic used for the treatment of gastric ulcers associated with Helicobacter pylori infection; it exhibits antibacterial activity against H. pylori with an MIC50 of 8 μg/mL; it shows synergistic effects when combined with oxolinic acid against H. pylori strains; it inhibits H. pylori F1-ATPase activity by interacting with enzyme thiol groups; it suppresses lipolytic activity of H. pylori, reducing lipase activity by 21% and phospholipase A activity by 60%.